(RTTNews) - XBiotech Inc. (XBIT) said the company is developing a new therapy, FLUVID, for treating illness caused by combined infections with influenza and COVID-19. This therapy will combine XBiotech's influenza True Human antibodies together with its recently discovered COVID-19 antibodies into one treatment.
John Simard, XBiotech CEO, said: "We believe a combination antibody therapy is the best way to prepare for flu season or a larger influenza pandemic outbreak that may occur in combination with COVID-19. We now have candidate therapeutics to treat real-world infections which will involve multiple pathogens and co-infections."
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.